Theleme Partners LLP

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$1.7B
Signature - Title
Lucy Elwes - Chief Compliance Officer
Location
London, United Kingdom
Summary
This page shows a list of all the recent 13F filings made by Theleme Partners LLP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Theleme Partners LLP reported 10 stock holdings with total value $1.7B as of Q3 2024. Top holdings included MRNA, SCHW, TRU, EFX, and HRI.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 10 $1.7B +$303M -$316M -$12.8M MRNA, SCHW, TRU, EFX, HRI 13F-HR 11/14/2024, 12:52 PM
Q2 2024 8 $2.01B +$232M -$120M +$112M MRNA, SCHW, WFC, TRU, HRI 13F-HR 8/13/2024, 05:45 PM
Q1 2024 7 $1.82B +$124M -$349M -$225M MRNA, SCHW, WFC, HRI, TRU 13F-HR 5/14/2024, 10:34 AM
Q4 2023 9 $1.9B +$138M -$453M -$315M MRNA, SCHW, WFC, HRI, TSM 13F-HR 2/13/2024, 09:55 AM
Q3 2023 10 $1.99B +$188M -$205M -$17.1M MRNA, SCHW, WFC, QCOM, URI 13F-HR 11/13/2023, 06:01 PM
Q2 2023 9 $2.21B +$280M -$250M +$29.9M MRNA, WFC, SCHW, URI, AA 13F-HR 8/11/2023, 06:21 PM
Q1 2023 11 $2.33B +$338M -$386M -$47.8M MRNA, WFC, SCHW, AA, QCOM 13F-HR 5/12/2023, 05:35 PM
Q4 2022 10 $2.6B +$237M -$198M +$38.4M MRNA, WFC, SCHW, AA, URI 13F-HR 2/10/2023, 04:14 PM
Q3 2022 10 $2.05B +$58.8M -$253M -$194M MRNA, WFC, SCHW, META, AA 13F-HR 11/14/2022, 12:12 PM
Q2 2022 12 $2.5B +$167M -$95.7M +$71.7M MRNA, WFC, LRCX, META, AA 13F-HR 8/12/2022, 11:14 AM
Q1 2022 11 $3.13B +$623M -$298M +$324M MRNA, WFC, AA, LRCX, META 13F-HR 5/13/2022, 01:37 PM
Q4 2021 9 $3.25B +$704M -$574M +$131M MRNA, WFC, AA, META, MU Restatement 5/26/2022, 12:11 PM
Q3 2021 7 $3.5B +$368M -$1.15B -$780M MRNA, WFC, META, AA, TMUS Restatement 5/26/2022, 12:04 PM
Q2 2021 9 $3.42B +$203M -$621M -$418M MRNA, WFC, TMUS, ADI, MU 13F-HR 8/13/2021, 02:26 PM
Q1 2021 12 $2.99B +$438M -$730M -$293M MRNA, WFC, TMUS, AZO, MU 13F-HR 5/13/2021, 12:36 PM
Q4 2020 15 $2.87B +$1.04B -$731M +$310M WFC, MRNA, TMUS, CARR, MU 13F-HR 2/12/2021, 04:04 PM
Q3 2020 15 $2.04B +$275M -$347M -$72.2M MRNA, WFC, URI, VMC, BKNG 13F-HR 11/13/2020, 02:48 PM
Q2 2020 14 $1.97B +$542M -$238M +$304M MRNA, WFC, URI, VMC, BKNG 13F-HR 8/13/2020, 07:34 PM
Q1 2020 13 $1.22B +$449M -$577M -$128M WFC, MRNA, URI, BA, MU 13F-HR 5/14/2020, 05:39 PM
Q4 2019 7 $1.78B +$78.6M -$406M -$327M WFC, BAC, URI, AXP, MRNA 13F-HR 2/13/2020, 10:03 AM
Q3 2019 10 $1.89B +$239M -$114M +$125M WFC, BAC, URI, SCHW, AXP 13F-HR 11/13/2019, 02:54 PM
Q2 2019 9 $1.68B +$357M -$354M +$3.31M WFC, BAC, SCHW, URI, KLAC 13F-HR 8/13/2019, 08:38 PM
Q1 2019 8 $1.67B +$271M -$355M -$84M BAC, WFC, SCHW, UTX, AXP 13F-HR 5/15/2019, 02:19 PM
Q4 2018 9 $1.64B +$154M -$59.8M +$93.7M WFC, SCHW, BAC, UTX, SPGI 13F-HR 2/13/2019, 06:12 PM
Q3 2018 7 $1.83B +$68.1M -$159M -$91M WFC, SCHW, BAC, UTX, SPGI 13F-HR 11/13/2018, 04:29 PM
Q2 2018 8 $1.93B +$244M -$272M -$28.8M SCHW, WFC, BAC, BACWSA, UTX 13F-HR 8/13/2018, 03:52 PM
Q1 2018 7 $1.99B +$158M -$88.4M +$69.9M SCHW, WFC, BAC, BACWSA, SPGI 13F-HR 5/14/2018, 01:45 PM
Q4 2017 6 $1.96B +$129M -$267M -$138M SCHW, WFC, BAC, BACWSA, SPGI 13F-HR 2/14/2018, 10:32 AM
Q3 2017 7 $1.81B +$77.1M -$89.9M -$12.8M BAC, SCHW, WFC, BACWSA, SPGI 13F-HR 11/13/2017, 10:50 AM
Q2 2017 6 $1.77B +$13.3M -$184M -$171M SCHW, BAC, WFC, BACWSA, SPGI 13F-HR 8/11/2017, 01:24 PM
Q1 2017 7 $1.87B +$104M -$115M -$10.5M SCHW, BAC, WFC, SPGI, BACWSA 13F-HR 5/12/2017, 12:59 PM
Q4 2016 7 $1.77B +$79.4M -$54.8M +$24.7M SCHW, BAC, WFC, SPGI, BACWSA 13F-HR 2/13/2017, 10:22 AM
Q3 2016 6 $1.39B +$162M -$245M -$82.2M SCHW, BAC, WFC, SPGI, CHTR 13F-HR 11/14/2016, 02:23 PM
Q2 2016 7 $1.33B +$203M -$344M -$141M WFC, SCHW, BAC, VMC, SPGI 13F-HR 8/12/2016, 10:06 AM
Q1 2016 8 $1.49B +$216M -$106M +$111M WFC, SCHW, BAC, VMC, MHFI 13F-HR 5/13/2016, 10:17 AM
Q4 2015 8 $1.52B +$57.2M -$66.1M -$8.98M WFC, SCHW, BAC, VMC, MHFI 13F-HR 2/12/2016, 11:02 AM
Q3 2015 8 $1.41B +$106M -$127M -$21.2M WFC, SCHW, BAC, VMC, MHFI 13F-HR 11/13/2015, 01:23 PM
Q2 2015 9 $1.57B +$179M -$173M +$5.61M WFC, SCHW, BAC, MHFI, VMC 13F-HR 8/13/2015, 11:31 AM
Q1 2015 9 $1.49B +$165M -$332M -$167M WFC, SCHW, BAC, MHFI, MSFT 13F-HR 5/14/2015, 09:56 AM
Q4 2014 8 $1.67B +$221M -$131M +$90.6M WFC, SCHW, BAC, MHK, MHFI 13F-HR 2/13/2015, 02:56 PM
Q3 2014 8 $1.51B +$91M -$128M -$37M WFC, SCHW, BAC, MHFI, MHK 13F-HR 11/13/2014, 10:34 AM
Q2 2014 10 $1.5B +$142M -$207M -$65.7M WFC, SCHW, BAC, MHFI, LOW 13F-HR 8/13/2014, 01:18 PM
Q1 2014 12 $1.53B +$143M -$349M -$206M WFC, SCHW, BAC, MHFI, LOW 13F-HR 5/14/2014, 10:13 AM
Q4 2013 14 $1.69B $0 $0 WFC, SCHW, AXP, BAC, MHFI 13F-HR 2/13/2014, 09:21 AM